Walk with our team to Cure Cystic Fibrosis
Carpenter Conquerors
Carpenter Conquerors
2025 will be our 16th year of taking Great Strides for the Cystic Fibrosis Foundation.
During this short time, amazing change in treatment have been developed. Yesterday we pick up up a new type of albuterol for breathing treatments and on Dec 20th, the FDA approved the latest CFTR modulator "Alyftrek" which is the next generation, following the also strangely named "Trikafta" and "Kalydeko".
While the CF Foundation has made incredible progress, not everyone with CF can benefit from this newest treatment and developing more specialized treatments will require time, funding, and persistence – but with you on our team – we are ready to go the distance.
During this short time, amazing change in treatment have been developed. Yesterday we pick up up a new type of albuterol for breathing treatments and on Dec 20th, the FDA approved the latest CFTR modulator "Alyftrek" which is the next generation, following the also strangely named "Trikafta" and "Kalydeko".
While the CF Foundation has made incredible progress, not everyone with CF can benefit from this newest treatment and developing more specialized treatments will require time, funding, and persistence – but with you on our team – we are ready to go the distance.
Comments